Back

Troponin elevation and vascular involvement post-COVID-19

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling Vascular Biology and Physiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Anna Kamdar

Glasgow (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Discussant - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling
Presentation thumbnail
Raised high sensitivity Troponin T (Hs-TnT) assays in non-ACS medical admissions and long term outcomes
Doctor S. Mckittrick (Castlebar, IE)
Abstract Slides Video
Presentation thumbnail
Circulating MicroRNA profile in coronary artery disease
Mr S. Kumar (New Delhi, IN)
Abstract Slides Video
Presentation thumbnail
The product of bilirubin and trigliseride is the most significant predictor of severe FIB-4 index of liver disease in cardiac patients
Doctor S. Celik (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Association of interleukin gene polymorphisms with coronary artery disease severity
Miss M. Liu (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection.
thumbnail
Congress Presentation
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: the PARACOR-19 randomized clinical trial
thumbnail
Congress Presentation
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources